TEK and hepatocellular carcinoma: Recent studies indicated that exosomal ANGPT2 secreted by HCC cells can induce tumor angiogenesis via a novel pathway that is different from the classic ANGPT2/Tie2 pathway, and blocking ANGPT2 is a promising therapeutic strategy for HCC [32].